184 related articles for article (PubMed ID: 32572567)
1. Effect of nicorandil administration on cardiac burden and cardio-ankle vascular index after coronary intervention.
Sato S; Takahashi M; Mikamo H; Kawazoe M; Iizuka T; Shimizu K; Noro M; Shirai K
Heart Vessels; 2020 Dec; 35(12):1664-1671. PubMed ID: 32572567
[TBL] [Abstract][Full Text] [Related]
2. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
[TBL] [Abstract][Full Text] [Related]
3. Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.
Miyoshi T; Ejiri K; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Kawai Y; Sato T; Sato K; Oka T; Takahashi N; Sakuragi S; Mima A; Enko K; Hosogi S; Nanba S; Hirami R; Nakamura K; Ito H;
Int J Cardiol; 2017 Jun; 236():36-42. PubMed ID: 28214082
[TBL] [Abstract][Full Text] [Related]
4. Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study.
Hirohata A; Yamamoto K; Hirose E; Kobayashi Y; Takafuji H; Sano F; Matsumoto K; Ohara M; Yoshioka R; Takinami H; Ohe T
EuroIntervention; 2014 Jan; 9(9):1050-6. PubMed ID: 24457276
[TBL] [Abstract][Full Text] [Related]
5. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
[TBL] [Abstract][Full Text] [Related]
6. Clinical potential of oral nicorandil to improve myocardial fatty acid metabolism after percutaneous coronary intervention in hemodialysis patients.
Nishimura M; Okamoto Y; Tokoro T; Sato N; Nishida M; Hashimoto T; Kobayashi H; Yamazaki S; Okino K; Iwamoto N; Takahashi H; Ono T
Nephron Clin Pract; 2014; 126(1):24-32. PubMed ID: 24434794
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention.
Yang J; Zhang J; Cui W; Liu F; Xie R; Yang X; Gu G; Zheng H; Lu J; Yang X; Zhang G; Wang Q; Geng X
Anatol J Cardiol; 2015 Feb; 15(2):125-31. PubMed ID: 25252296
[TBL] [Abstract][Full Text] [Related]
8. Effect of nitroglycerin administration on cardio-ankle vascular index.
Shimizu K; Yamamoto T; Takahashi M; Sato S; Noike H; Shirai K
Vasc Health Risk Manag; 2016; 12():313-9. PubMed ID: 27536126
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
[TBL] [Abstract][Full Text] [Related]
10. Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention: a randomized controlled trial.
Kim SJ; Kim W; Woo JS; Ha SJ; Kang WY; Hwang SH; Kang DG; Lee SU; Cho SK; Im JS; Kim W
Int J Cardiol; 2012 Jun; 158(1):88-92. PubMed ID: 21256606
[TBL] [Abstract][Full Text] [Related]
11. Effect of intravenous nicorandil and preexisting angina pectoris on short- and long-term outcomes in patients with a first ST-segment elevation acute myocardial infarction.
Ishii H; Ichimiya S; Kanashiro M; Amano T; Ogawa Y; Mitsuhashi H; Sakai S; Uetani T; Murakami R; Naruse K; Murohara T; Matsubara T
Am J Cardiol; 2007 May; 99(9):1203-7. PubMed ID: 17478142
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention.
Zhao XT; Zhang CF; Liu QJ
BMC Cardiovasc Disord; 2019 Jun; 19(1):144. PubMed ID: 31200660
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC).
Kawakita N; Ejiri K; Miyoshi T; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Nakamura K; Ito H;
PLoS One; 2018; 13(4):e0194623. PubMed ID: 29659585
[TBL] [Abstract][Full Text] [Related]
14. Protective Effect of Remote Ischemic Preconditioning on Myocardial Damage After Percutaneous Coronary Intervention in Stable Angina Patients With Complex Coronary Lesions - Subanalysis of a Randomized Controlled Trial.
Ejiri K; Miyoshi T; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Nakamura K; Ito H;
Circ J; 2018 Jun; 82(7):1788-1796. PubMed ID: 29669963
[TBL] [Abstract][Full Text] [Related]
15. Routine Fractional Flow Reserve Measurement After Percutaneous Coronary Intervention.
van Bommel RJ; Masdjedi K; Diletti R; Lemmert ME; van Zandvoort L; Wilschut J; Zijlstra F; de Jaegere P; Daemen J; van Mieghem NM
Circ Cardiovasc Interv; 2019 May; 12(5):e007428. PubMed ID: 31018666
[TBL] [Abstract][Full Text] [Related]
16. Effects of nicorandil infusion on ECG parameters in patients with unstable angina pectoris and percutaneous coronary intervention.
Wang W; Zhang X; Chen K; Yin L; Gong M; Liu Y; Tse G; Wu L; Li G; Liu T
Ann Noninvasive Electrocardiol; 2020 Jul; 25(4):e12736. PubMed ID: 31849155
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory.
Jang HJ; Koo BK; Lee HS; Park JB; Kim JH; Seo MK; Yang HM; Park KW; Nam CW; Doh JH; Kim HS
Eur Heart J; 2013 Jul; 34(27):2055-62. PubMed ID: 23396491
[TBL] [Abstract][Full Text] [Related]
18. Preservation of myocardial viability within the risk area by intravenous nicorandil before primary coronary intervention in patients with acute myocardial infarction.
Umemura S; Nakamura S; Sugiura T; Tsuka Y; Shimojo M; Baden M; Iwasaka T
Nucl Med Commun; 2008 Nov; 29(11):956-62. PubMed ID: 18836373
[TBL] [Abstract][Full Text] [Related]
19. Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.
Nawa T; Nishigaki K; Kinomura Y; Tanaka T; Yamada Y; Kawasaki M; Minatoguchi S
Int J Cardiol; 2015 Sep; 195():228-34. PubMed ID: 26048382
[TBL] [Abstract][Full Text] [Related]
20. Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes.
Hattori H; Minami Y; Mizuno M; Yumino D; Hoshi H; Arashi H; Nuki T; Sashida Y; Higashitani M; Serizawa N; Yamada N; Yamaguchi J; Mori F; Shiga T; Hagiwara N
Heart Vessels; 2013 May; 28(3):345-51. PubMed ID: 22526380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
